NEW YORK, Aug.  10, 2026  (GLOBE NEWSWIRE) -- Kaplan Fox &amp; Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (&#34;Alignment Healthcare&#34; or the &#34;Company&#34;)

ALHC

Kaplan Fox Alerts Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to an Ongoing Securities Investigation

ALHC Investigation by Kaplan Fox Weighs on Shares; watch restatement risk

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>NEW YORK, Aug.  10, 2026  (GLOBE NEWSWIRE) -- Kaplan Fox &amp;amp; Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. (&amp;#34;Alignment Healthcare&amp;#34; or the &amp;#34;Company&amp;#34;)</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>A whistleblower alleges Alignment Healthcare inflated EBITDA via misclassified operating expenses, prompting a Kaplan Fox investigation. The July 8, 2026 news led ALHC to close at $20.03, down 16.7% from prior close, signaling investor concern over potential restatements and longer-term earnings risk. No regulatory action announced yet, but scrutiny could affect liquidity and valuation.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Whistleblower alleges accounting irregularities inflating EBITDA; expenses misclassified as capex. Stock fell 16.7% to $20.03 on July 8, 2026.</li><li>Kaplan Fox investigating Alignment Healthcare securities violations. Public plaintiffs&#039; firm; no outcome yet.</li><li>Adjusted EBITDA concerns; potential restatement risk. Financial impact uncertain until investigation concludes.</li><li>No regulatory action announced yet; situation may remain volatile. Investors should monitor updates.</li><li>Analysts reassess ALHC valuation pending disclosures. Near-term volatility may persist.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Alignment Healthcare, Inc. (ALHC)</strong>: Target of securities investigation; potential earnings impact if restatements occur.</li><li><strong>Kaplan Fox &amp; Kilsheimer LLP (N/A)</strong>: Plaintiffs&#039; firm leading the inquiry; publicized legal exposure but not a company issuer.</li></ul>
  </section>

  <section data-block="category">
    <h3>Legal</h3>
    <p>Category: Legal. The piece centers on an investor-focused securities investigation, a governance and financial reporting risk that could affect ALHC&#039;s stock through future disclosures and potential restatements.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>July 8, 2026 share drop of 16.7% following the investigation news.</li><li>Kaplan Fox investigation adds legal risk and potential ongoing disclosures.</li><li>No regulatory action announced yet; heightened near-term volatility likely.</li><li>ALHC valuation may reprice on further detail about accounting allegations.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>July 8, 2026: whistleblower complaint alleges &#039;accounting irregularities&#039; inflating EBITDA and misclassifying expenses as capex.</li><li>ALHC closed at $20.03 on July 8, 2026, down 16.7%.</li><li>Kaplan Fox &amp; Kilsheimer LLP leading the investigation.</li><li>Adjusted EBITDA cited as a central metric in reported earnings and executive compensation.</li><li>Whistleblower claims millions of operating expenses misclassified as capital expenditures.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Bearish near-term; potential downside unless material restatement risks are clarified.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p align="justify">NEW YORK, Aug.  10, 2026  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=XdJxySxoX1nbgMhsyEeKReVQjTxnLQR_2DccJr4vR-H06jWV2eUgCe2hN6_k4AcmWmhOSVsjdqSQI2kRCGl6VLPhuJr2yRu_KWLXH3P6LPyzKMXesdisxtw7_5tXO0mJLyCNNLdrN5beOWfMWKnm4AfEWOd7ylAQf3cCRSDnzaSULaIV1jxArLmvxEUa8AH3MuQgHBfWHvf5RJBuEJPWx-YZWTmUlkbnmCAXJ2PjOjBk2hm5rPIpRXlXBA1EiT-a" rel="nofollow" target="_blank">Kaplan Fox &amp; Kilsheimer LLP</a> is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/ALHC">ALHC</a>).</p>  <p align="center"><a href="https://www.globenewswire.com/Tracker?data=TFlGvze0TU6CfGYpZqSI6fSzFYmm-RK_P_K4LF8letQOArk_24drOncSO3rP8rIQhI_ewFzNKsBoWp8UrDgulwhidw-RAp0rdranmTgJP1MPTdlbITuU4wRM82DSW4DMqKzP5vukkj6WkDYpgiGxt9Vq439rtKbAk2kiPYlvSLNH7zKccmPAP9sZfjvmhAtBVnUkf3iwpd7drjAAI1VHm7MieH3r9-vszfDkHHf4Mul-dbG07G8Di_NAFXda-o73ibk6rOiw1Fm0Q7H3ceHHbLCgrSNK808317hzaXw9JNLlqKiILcCUUDVeIYz6wFNQCarfXcIEbiqExPBmqO3GkKGyrauBbUF4nsjzW5ScHXE=" rel="nofollow" target="_blank">CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION</a></p>  <p align="justify"><strong>If you are an Alignment Healthcare investor and have suffered losses, or if you have information that could assist in the Alignment Healthcare investigation, you may </strong><a href="https://www.globenewswire.com/Tracker?data=TFlGvze0TU6CfGYpZqSI6VrKqPtaOKhrDVfm_T9-gmMOoBK-LA88uQL91yTufpJ02HkMEqHGYaP6HhSvOZG8ksVXqx0yw6Igg17ybxXTSFPIXT2DOi4HiXh-u8Tn_PLj7IZDhfn5WwDn4AZce6VCxddWmWpe55qSAeaYRKweISA_Fr4c5tAzwd5Ws7wktYv_RA0RyeBEMnpNp7lX_7dX3yP4ToXJQnnTm1CsahEVNcSWXSrxl4YlB0SKg0sqMuZWapcZqfrKgz6NdVKDkyCnpaMHMCDuBi_bk7d0vf8Fj4g=" rel="nofollow" target="_blank"><strong>CLICK HERE</strong></a><strong> to contact us. You may also contact Kaplan Fox by emailing </strong><a href="https://www.globenewswire.com/Tracker?data=Fk2ilzgaY7PU162vpvzI7XVLuDHxNiTI82MFzHdv6IaVKg7IQErDGJ78YnYz2bp1L-pkqExZtU0X7_7eCU8OjJ6AN9UhkGaCYUVjMq36bj8=" rel="nofollow" target="_blank"><strong>pmayer@kaplanfox.com</strong></a><strong> or by calling (646) 315-9003.</strong></p>  <p align="justify">On July 8, 2026, news emerged that a former Alignment Healthcare executive had filed a whistleblower complaint alleging the Company engaged in "accounting irregularities" that "artificially inflated" Alignment Healthcare’s previously reported and projected financial results, including "Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization ("Adjusted EBITDA"), a key non-GAAP financial metric central to the Company’s reported financial performance and executive compensation structure." According to the lawsuit "millions of dollars in operating expenses had been systematically misclassified as capital expenditures."</p>  <p align="justify">Following this news, on July 8, 2026, the price of Alignment Healthcare stock fell $4.02 per share, or 16.7%, to close at $20.03 per share.</p>  <p align="justify"><strong>WHY CONTACT KAPLAN FOX?</strong></p>  <p align="justify">Kaplan Fox &amp; Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.</p>  <p align="justify">Kaplan Fox is widely regarded as one of the nation&#39;s premier plaintiffs&#39; securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in <em>In re Bank of America</em>—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in <em>ATRS v. Allianz Global Investors</em>, and a $475 million settlement in <em>In re Merrill Lynch</em>.</p>  <p align="justify">For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.</p>  <p align="justify">This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.</p>  <p align="justify">If you have any questions about this investigation, please contact:</p>  <p align="justify"><strong>CONTACT:</strong><br></br>Pamela A. Mayer<br></br><a href="https://www.globenewswire.com/Tracker?data=Ip5bb-wE4dSkUnQWs49yMlNrHqJ4lXknXzjGXEBXOmnb-Izd_RMeiLHIsHy7llP0ffHzt_ieogZYaNw1H7eV7ufinOFIuz8yTP_diV4dR-1Oq3IyG4zPzat0hTnKN1eK" rel="nofollow" target="_blank">KAPLAN FOX &amp; KILSHEIMER LLP</a><br></br>800 Third Avenue, 38th Floor<br></br>New York, New York 10022<br></br>(646) 315-9003<br></br><a href="https://www.globenewswire.com/Tracker?data=Fk2ilzgaY7PU162vpvzI7XVLuDHxNiTI82MFzHdv6IbOmSZYOspsX0uMfJf4wU6kKkKOYqLjUFrii6NfOY_dYDucuhjNIZ3Lq5H0TXUfLPs=" rel="nofollow" target="_blank">pmayer@kaplanfox.com</a></p>  <p>Laurence D. King<br></br><a href="https://www.globenewswire.com/Tracker?data=Ip5bb-wE4dSkUnQWs49yMlNrHqJ4lXknXzjGXEBXOmnM8G65kuUsKGnOTRHhH6kJtIkVzDh4NZDZxMrynGbdsApW_VCTvuzUFV7yBXBOuCzqmuZMvhjF40sOaIco9LIE" rel="nofollow" target="_blank">KAPLAN FOX &amp; KILSHEIMER LLP</a><br></br>1999 Harrison Street, Suite 1501<br></br>Oakland, California 94612<br></br>(415) 772-4704<br></br><a href="https://www.globenewswire.com/Tracker?data=fsaxyl3QmX8e-axKybLkydcCx-CFbHRA8hmx0wW7Q8Z3NNee21tRflTxVaKJq3kh758cANyn2vIHpRH8TnyUmuuEaVKX5IVpt8D_qfWYuhY=" rel="nofollow" target="_blank">lking@kaplanfox.com</a></p>  <p>Contacting or submitting information to Kaplan Fox &amp; Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.</p>  <p><a href="https://www.globenewswire.com/Tracker?data=KsUWT2hYd0yYtP0y4v-ran3DMs2q7JPifjUQupeOj5lEah_1L1CP-EPv7DdSTlZbMD6Cx9kji0r55Fxic6qyR5P8r1YTBWx6Amxbm5wowVPH96FrDOfSLLmqgC3SoEgDxy9um6ejzCjR4d4Ua-d6u15l41eNSGPI5D_tW7D-1x8BZVZ64XVZak1zT0E3UXRNrzrHz5dGEntB0XUipsXNa1zMRDGm5gEUaPt2SQdotcffKn6dG4fk0NJdayDzj-cq" rel="nofollow" target="_blank">https://www.kaplanfox.com/case/alignment-healthcare-investigation-learn-more/</a></p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTgwNjgzOSM3NzY3NjMxIzIwMjA4OTE="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/NDA4MGRjZTctYzlhMC00NmRhLWJhYjMtNWY0MzFhNmE5YTQzLTEwMzE5OTktMjAyNi0wOC0xMC1lbg==/tiny/Kaplan-Fox-Kilsheimer-LLP.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/711aa439-0e7d-4b53-8daa-452f70fe946a"><img src="https://ml.globenewswire.com/media/711aa439-0e7d-4b53-8daa-452f70fe946a/small/pr-resizing-kaplan-fox-tagline-logo-color-jpg.jpg" border="0" width="150" height="29" alt="Primary Logo"></img></a></p>

A whistleblower alleges Alignment Healthcare inflated EBITDA via misclassified operating expenses, prompting a Kaplan Fox investigation. The July 8, 2026 news led ALHC to close at $20.03, down 16.7% from prior close, signaling investor concern over potential restatements and longer-term earnings risk. No regulatory action announced yet, but scrutiny could affect liquidity and valuation.

News insight

Kaplan Fox Alerts Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to an Ongoing Securities Investigation

AI summary

Sentiment rationale

Key facts

Legal